NEW YORK--(BUSINESS WIRE)--Haug Partners LLP is proud to welcome Brian V. Slater to our New York office.
Brian V. Slater has served as lead litigation counsel for over 25 years for life sciences innovators, and has led trial teams to successes in federal district courts, before the Patent Trial and Appeal Board (PTAB), and in arbitration.
Brian has an extensive understanding of Hatch-Waxman patent litigation against ANDA challengers. His diverse patent and trade secret litigation experience also includes cases involving biologics, medical devices, diagnostic kits, aircraft composites, toner cartridges, automotive parts, vending machines, and magazine cover coatings.
Brian previously served as Chair of Life Sciences at Kramer Levin Naftalis & Frankel LLP. Previously, he spent over 20 years at Fitzpatrick, Cella, Harper & Scinto (now Venable LLP), where he served on the management committee and was Chair of the Due Diligence practice.
Brian attended the University of Pennsylvania ( LL.M.) and the University of Strathclyde (LL.B.) with First Class Honors.
Sandra Kuzmich, Managing Partner of the firm, said this about Brian: “In this very difficult time for all as we manage through the Covid 19 crisis, we are extremely pleased to welcome Brian Slater to our partnership. Brian has demonstrated excellence as a lead trial lawyer for pre-eminent pharma companies such as Merck, Sanofi and Gilead. Brian brings to us his experience as Chair of the Life Sciences practice at Kramer Levin and before that more than 20 years at Fitzpatrick Cella. Brian’s joining Haug Partners is a fabulous addition to the Firm’s already deep experience in the Hatch Waxman arena and global expertise in intellectual property.”
Haug Partners LLP is a national law firm that provides integrated, multidisciplinary legal services in the areas of intellectual property, FDA law, and antitrust and commercial transactions. The firm has offices in New York, Washington, D.C., and Boston.